Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Current Opinion in Molecular Therapeutics|June 5, 2002
Antisense treatment of caliciviridae: an emerging disease agent of animals and humansAlvin W Smith, David O Matson, David A Stein, et al.
BMC Research Notes|July 5, 2018
Profile of the 2016 dengue outbreak in NepalRamawatar Prasad Khetan, David A Stein, Santosh Kumar Chaudhary, et al.
Journal of Virology|May 14, 2004
Antisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growthBenjamin W Neuman, David A Stein, Andrew D Kroeker, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2006
Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomersQing Ge, Manoj Pastey, Darwyn Kobasa, et al.
Assay and Drug Development Technologies|October 27, 2010
High-content assay to identify inhibitors of dengue virus infectionDavid Shum, Jessica L Smith, Alec J Hirsch, et al.
Journal of Virology|March 30, 2005
Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomersRichard M Kinney, Claire Y-H Huang, Becky C Rose, et al.
The Journal of Antimicrobial Chemotherapy|June 24, 2008
Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virusDavid A Stein, Claire Y-H Huang, Shawn Silengo, et al.
Pageof 7